TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01 Other Events.
On April 4, 2017, Tonix Pharmaceuticals Holding Corp. issued a
press release announcing the closing of its public offering of
1,800,000 shares of its common stock. The shares were sold at a
public offering price of $4.45 per share, less underwriting
discounts. A copy of the press release is included as
Exhibit99.01 to this Current Report on Form8-K.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
| 99.01 |
Press Release, dated April 4, 2017, issued by Tonix Pharmaceuticals Holding Corp. |
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Recent Trading Information
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) closed its last trading session down -0.03 at 4.39 with 1,092,158 shares trading hands.
